PRMEPrime Medicine, Inc.
$3.58-39% 1Y
$3.58
$2.7052 weeks$6.45
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +3% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PRME is trading
Prime Medicine, Inc. is −39% over the past year while the S&P 500 is +18%: 57 points behind the market.
−39%
1-year return · S&P 500 +18%
- vs 200-day average
- +2.9%
vs 200-day average · close to trend
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- 45%
Below its 52-week high
Details›
- Last close2026-10-08
- $3.58
- 1 monthS&P 500 +1.6%
- +2.9%
- 1 yearS&P 500 +18%
- −39%
- vs 50-day average$3.27
- +9.3%
- 52-week high
- $6.45
- 52-week low
- $2.70
- Annualised volatility
- 100%
| Year | Return |
|---|---|
| 2026 (year to date) | +3.2% |
| 2025 | +19% |
| 2024 | −67% |
| 2023 | −52% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 1 of 4 | −7.0% |
| Feb | 4 | 2 of 4 | +10% |
| Mar | 4 | 0 of 4 | −22% |
| Apr | 4 | 2 of 4 | −7.2% |
| May | 4 | 2 of 4 | −0.08% |
| Jun | 4 | 3 of 4 | +25% |
| Jul | 4 | 3 of 4 | +11% |
| Aug | 4 | 1 of 4 | −6.5% |
| Sep | 4 | 1 of 4 | +4.6% |
| Oct | 4 | 2 of 4 | −6.3% |
| Nov | 4 | 1 of 4 | −8.7% |
| Dec | 4 | 2 of 4 | +2.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.